PUBLISHER: IMARC | PRODUCT CODE: 1291344
PUBLISHER: IMARC | PRODUCT CODE: 1291344
Hemoglobinopathies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global hemoglobinopathies market size reached US$ 9.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.3 Billion by 2028, exhibiting a growth rate (CAGR) of 9.39% during 2023-2028.
Hemoglobinopathies is genetic blood disorder that causes structural and production abnormalities in hemoglobin molecules. Sickle cell, thalassemia, hemoglobin C, and beta-thalassemia are some of the common types of hemoglobinopathies. Hemoglobinopathies are detected by genetic testing, hemoglobin by high-performance liquid chromatography, routine red blood cell (RBC) count, hemoglobin isoelectric focusing (Hb IEF), and hemoglobin electrophoresis (Hb ELP) test. Pale skin, shortness of breath, cold hands or feet, tiredness, pain, and swelling in the hands and feet are a few of the most common symptoms hemoglobinopathies. Some of the widely used hemoglobinopathies treatment solutions include antibiotics, ACE inhibitors, stem-cell transplantation, blood transfusions, hydroxyurea, and analgesic.
Hemoglobinopathies Market Trends:
The increasing prevalence of various medical conditions, such as sickle cell disease (SCD) and thalassemia, is one of the key factors driving the growth of the market. Hemoglobinopathies are caused by abnormal hemoglobin that deforms and damages red blood cells and makes them hard and sticky. In line with this, the rising prevalence of anemia, especially among the geriatric population, which is also susceptible to various other chronic ailments, is favoring the market growth. Various technological advancements, such as the development of CRISPR-Cas9 technology to cure hemoglobinopathies by editing, removing, adding, or altering genes and modifying the DNA, are providing an impetus to the market growth. In line with this, the widespread adoption of gene therapy for the treatment of hemoglobinopathy is favoring market growth. Other factors, such as the significant expansion in the healthcare industry, along with the implementation of various government initiatives to promote research and development (R&D) activities to introduce novel therapies for treating hemoglobinopathies at affordable costs is anticipated to provide a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hemoglobinopathies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, treatment, test type and end user.
Breakup by Type:
Thalassemia
Alpha Thalassemia
Beta Thalassemia
Sickle Cell Disease
Others
Breakup by Treatment:
Hemoglobinopathies Market Trends:
The increasing prevalence of various medical conditions, such as sickle cell disease (SCD) and thalassemia, is one of the key factors driving the growth of the market. Hemoglobinopathies are caused by abnormal hemoglobin that deforms and damages red blood cells and makes them hard and sticky. In line with this, the rising prevalence of anemia, especially among the geriatric population, which is also susceptible to various other chronic ailments, is favoring the market growth. Various technological advancements, such as the development of CRISPR-Cas9 technology to cure hemoglobinopathies by editing, removing, adding, or altering genes and modifying the DNA, are providing an impetus to the market growth. In line with this, the widespread adoption of gene therapy for the treatment of hemoglobinopathy is favoring market growth. Other factors, such as the significant expansion in the healthcare industry, along with the implementation of various government initiatives to promote research and development (R&D) activities to introduce novel therapies for treating hemoglobinopathies at affordable costs is anticipated to provide a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hemoglobinopathies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, treatment, test type and end user.
Breakup by Type:
Thalassemia
Alpha Thalassemia
Beta Thalassemia
Sickle Cell Disease
Others
Breakup by Treatment:
Blood Transfusion
Stem-cell Transplantation
Analgesics
Antibiotics
ACE Inhibitors
Hydroxyurea
Others
Breakup by Test Type:
Red Blood Cell (RBC) Count
Genetic Testing
High Performance Liquid Chromatography (HPLC)
Hemoglobin Isoelectric Focusing (Hb IEF)
Hemoglobin Electrophoresis (Hb ELP)
Hemoglobin Solubility Test
Breakup by End User:
Hospitals and Clinics
Diagnostics Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bio-Rad Laboratories Inc., bluebird bio Inc., Bristol-Myers Squibb Company, Danaher Corporation, Emmaus Life Sciences Inc., Gamida-Cell Ltd., Global Blood Therapeutics Inc., Novartis AG, PerkinElmer Inc., Pfizer Inc., Prolong Pharmaceuticals LLC, Sangamo Therapeutics Inc. and Sysmex Corporation.
Key Questions Answered in This Report
1. What was the size of the global hemoglobinopathies market in 2022?
2. What is the expected growth rate of the global hemoglobinopathies market during 2023-2028?
3. What has been the impact of COVID-19 on the global hemoglobinopathies market?
4. What are the key factors driving the global hemoglobinopathies market?
5. What is the breakup of the global hemoglobinopathies market based on the type?
6. What is the breakup of the global hemoglobinopathies market based on the treatment?
7. What are the key regions in the global hemoglobinopathies market?
8. Who are the key players/companies in the global hemoglobinopathies market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Hemoglobinopathies Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Thalassemia
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Alpha Thalassemia
- 6.1.2.2 Beta Thalassemia
- 6.1.3 Market Forecast
- 6.2 Sickle Cell Disease
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Treatment
- 7.1 Blood Transfusion
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Stem-cell Transplantation
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Analgesics
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Antibiotics
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 ACE Inhibitors
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Hydroxyurea
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
8 Market Breakup by Test Type
- 8.1 Red Blood Cell (RBC) Count
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Genetic Testing
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 High Performance Liquid Chromatography (HPLC)
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Hemoglobin Isoelectric Focusing (Hb IEF)
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Hemoglobin Electrophoresis (Hb ELP)
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Hemoglobin Solubility Test
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Diagnostics Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Bio-Rad Laboratories Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 bluebird bio Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Bristol-Myers Squibb Company
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Danaher Corporation
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Emmaus Life Sciences Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.6 Gamida-Cell Ltd.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.7 Global Blood Therapeutics Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.8 Novartis AG
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 PerkinElmer Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Pfizer Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Prolong Pharmaceuticals LLC
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.12 Sangamo Therapeutics Inc.
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.13 Sysmex Corporation
- 15.3.13.1 Company Overview
- 15.3.13.2 Product Portfolio
- 15.3.13.3 Financials
- 15.3.13.4 SWOT Analysis
- 15.3.1 Bio-Rad Laboratories Inc.
List of Figures
- Figure 1: Global: Hemoglobinopathies Market: Major Drivers and Challenges
- Figure 2: Global: Hemoglobinopathies Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Hemoglobinopathies Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Hemoglobinopathies Market: Breakup by Type (in %), 2022
- Figure 5: Global: Hemoglobinopathies Market: Breakup by Treatment (in %), 2022
- Figure 6: Global: Hemoglobinopathies Market: Breakup by Test Type (in %), 2022
- Figure 7: Global: Hemoglobinopathies Market: Breakup by End User (in %), 2022
- Figure 8: Global: Hemoglobinopathies Market: Breakup by Region (in %), 2022
- Figure 9: Global: Hemoglobinopathies (Thalassemia) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Hemoglobinopathies (Thalassemia) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Hemoglobinopathies (Sickle Cell Disease) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Hemoglobinopathies (Sickle Cell Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Hemoglobinopathies (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Hemoglobinopathies (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Hemoglobinopathies (Blood Transfusion) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Hemoglobinopathies (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Hemoglobinopathies (Stem-cell Transplantation) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Hemoglobinopathies (Stem-cell Transplantation) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Hemoglobinopathies (Analgesics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Hemoglobinopathies (Analgesics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Hemoglobinopathies (Antibiotics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Hemoglobinopathies (Antibiotics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Hemoglobinopathies (ACE Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Hemoglobinopathies (ACE Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Hemoglobinopathies (Hydroxyurea) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Hemoglobinopathies (Hydroxyurea) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Hemoglobinopathies (Other Treatments) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Hemoglobinopathies (Other Treatments) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Global: Hemoglobinopathies (Red Blood Cell (RBC) Count) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Global: Hemoglobinopathies (Red Blood Cell (RBC) Count) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: Global: Hemoglobinopathies (Genetic Testing) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: Global: Hemoglobinopathies (Genetic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: Global: Hemoglobinopathies (High Performance Liquid Chromatography-HPLC) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: Global: Hemoglobinopathies (High Performance Liquid Chromatography-HPLC) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Global: Hemoglobinopathies (Hemoglobin Isoelectric Focusing-Hb IEF) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Global: Hemoglobinopathies (Hemoglobin Isoelectric Focusing-Hb IEF) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: Global: Hemoglobinopathies (Hemoglobin Electrophoresis-Hb ELP) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: Global: Hemoglobinopathies (Hemoglobin Electrophoresis-Hb ELP) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: Global: Hemoglobinopathies (Hemoglobin Solubility Test) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: Global: Hemoglobinopathies (Hemoglobin Solubility Test) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: Global: Hemoglobinopathies (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: Global: Hemoglobinopathies (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: Global: Hemoglobinopathies (Diagnostics Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: Global: Hemoglobinopathies (Diagnostics Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: Global: Hemoglobinopathies (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: Global: Hemoglobinopathies (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: North America: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: North America: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: United States: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: United States: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: Canada: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: Canada: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: Asia-Pacific: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: Asia-Pacific: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: China: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: China: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: Japan: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: Japan: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: India: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: India: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: South Korea: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: South Korea: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Australia: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Australia: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: Indonesia: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: Indonesia: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: Others: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: Others: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Europe: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Europe: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Germany: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Germany: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: France: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: France: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: United Kingdom: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: United Kingdom: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Italy: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 78: Italy: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 79: Spain: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 80: Spain: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 81: Russia: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 82: Russia: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 83: Others: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 84: Others: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 85: Latin America: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 86: Latin America: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 87: Brazil: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 88: Brazil: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 89: Mexico: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 90: Mexico: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 91: Others: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 92: Others: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 93: Middle East and Africa: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 94: Middle East and Africa: Hemoglobinopathies Market: Breakup by Country (in %), 2022
- Figure 95: Middle East and Africa: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 96: Global: Hemoglobinopathies Industry: SWOT Analysis
- Figure 97: Global: Hemoglobinopathies Industry: Value Chain Analysis
- Figure 98: Global: Hemoglobinopathies Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Hemoglobinopathies Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Hemoglobinopathies Market Forecast: Breakup by Type (in Million US$), 2023-2028
- Table 3: Global: Hemoglobinopathies Market Forecast: Breakup by Treatment (in Million US$), 2023-2028
- Table 4: Global: Hemoglobinopathies Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
- Table 5: Global: Hemoglobinopathies Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 6: Global: Hemoglobinopathies Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 7: Global: Hemoglobinopathies Market: Competitive Structure
- Table 8: Global: Hemoglobinopathies Market: Key Players
